As of October 2024, Travere Therapeutics has a market cap of $1.13B. This makes Travere Therapeutics the world's 7294th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $640.24M | -5.23% |
2023 | $675.56M | -57.25% |
2022 | $1.58B | -32.25% |
2021 | $2.33B | 13.89% |
2020 | $2.05B | 91.94% |
2019 | $1.07B | -37.25% |
2018 | $1.70B | 7.40% |
2017 | $1.58B | 11.30% |
2016 | $1.42B | -1.87% |
2015 | $1.45B | 57.60% |
2014 | $919.78M | 74.86% |
2013 | $526.02M | 108.96% |
2012 | $251.74M | - |